Financial Network Wealth Management LLC Eli Lilly & CO Transaction History

Financial Network Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$434.7 - $599.3 $178,661 - $246,312	411 New	411 $221,000
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $1,286 - $1,498	-4 Reduced 0.59%	673 $246,000
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $2,668 - $3,040	9 Added 1.35%	677 $219,000
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $83,619 - $98,181	-300 Reduced 30.99%	668 $217,000
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $54,165 - $70,062	-300 Reduced 23.66%	968 $222,000
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $165,423 - $218,894	1,268 New	1,268 $214,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Financial Network Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Network Wealth Management LLC with notifications on news.